Cindy Castado
14Patents
4h-index
13Co-inventors
53Inventor score
Filing activity: Oct 1, 2004 → Jun 29, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US8574596B2 | Pertussis antigens and use thereof in vaccination | Emerging Cross-Sectional Technologies | 9 | Active |
| US10093722B2 | Nucleotide sequences, vectors and host cells | Chemistry; Metallurgy | 6 | Active |
| US10377816B2 | Nucleotide sequences, vectors and host cells | Chemistry; Metallurgy | 5 | Active |
| US9290565B2 | Immunogenic composition | Chemistry; Metallurgy | 4 | Active |
| US9644024B2 | Nucleotide sequences, vectors and host cells | Chemistry; Metallurgy | 3 | Active |
| US9409974B2 | Immunogenic composition | Chemistry; Metallurgy | 3 | Active |
| US9669083B2 | Immunogenic composition comprising elements of C. difficile CDTb and/or CDTa proteins | Human Necessities | 3 | Active |
| US10548963B2 | Immunogenic composition for use in vaccination against staphylococci | Emerging Cross-Sectional Technologies | 2 | Active |
| US10040832B2 | UspA2 protein constructs and uses thereof | Emerging Cross-Sectional Technologies | 1 | Active |
| US11266733B2 | Viral antigens | Chemistry; Metallurgy | 0 | Active |
| US10745449B2 | UspA2 protein constructs and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US10947280B2 | UspA2 protein constructs and uses thereof | Emerging Cross-Sectional Technologies | 0 | Active |
| US11466292B2 | Compositions and methods of treatment | Chemistry; Metallurgy | 0 | Active |
| US9567377B2 | Immunogenic composition | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.